The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
ACLARIS THERAPEUTICS INC | COM | 00461U105 | 4,390 | 250,000 | SH | SOLE | 250,000 | 0 | 0 | ||
ALDEYRA THERAPEUTICS INC | COM | 01438T106 | 6,798 | 600,000 | SH | SOLE | 600,000 | 0 | 0 | ||
ALLOGENE THERAPEUTICS INC | COM | 019770106 | 7,172 | 275,000 | SH | SOLE | 275,000 | 0 | 0 | ||
AMICUS THERAPEUTICS INC | COM | 03152W109 | 2,555 | 265,000 | SH | SOLE | 265,000 | 0 | 0 | ||
ARVINAS INC | COM | 04335A105 | 15,785 | 205,000 | SH | SOLE | 205,000 | 0 | 0 | ||
ASCENDIS PHARMA A/S | SPONSORED ADR | 04351P101 | 17,759 | 135,000 | SH | SOLE | 135,000 | 0 | 0 | ||
BICYCLE THERAPEUTICS PLC | SPONSORED ADS | 088786108 | 6,072 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | ||
BIOGEN INC | COM | 09062X103 | 11,254 | 32,500 | SH | SOLE | 32,500 | 0 | 0 | ||
CASI PHARMACEUTICALS INC | COM | 14757U109 | 1,008 | 650,000 | SH | SOLE | 650,000 | 0 | 0 | ||
CATALYST BIOSCIENCES INC | COM NEW | 14888D208 | 4,330 | 1,000,000 | SH | SOLE | 1,000,000 | 0 | 0 | ||
CELLDEX THERAPEUTICS INC NEW | COM NEW | 15117B202 | 9,530 | 285,000 | SH | SOLE | 285,000 | 0 | 0 | ||
CEREVEL THERAPEUTICS HLDNG I | COM | 15678U128 | 1,922 | 75,000 | SH | SOLE | 75,000 | 0 | 0 | ||
CHIMERIX INC | COM | 16934W106 | 1,600 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | ||
CODEX DNA INC | COM | 192003101 | 770 | 35,000 | SH | SOLE | 35,000 | 0 | 0 | ||
COGENT BIOSCIENCES INC | COM | 19240Q201 | 12,976 | 1,600,000 | SH | SOLE | 1,600,000 | 0 | 0 | ||
CRINETICS PHARMACEUTICALS IN | COM | 22663K107 | 4,586 | 243,309 | SH | SOLE | 243,309 | 0 | 0 | ||
CTI BIOPHARMA CORP | COM | 12648L601 | 4,000 | 1,600,000 | SH | SOLE | 1,600,000 | 0 | 0 | ||
CURIS INC | COM NEW | 231269200 | 1,994 | 247,124 | SH | SOLE | 247,124 | 0 | 0 | ||
ELEVATION ONCOLOGY INC | COM | 28623U101 | 1,357 | 100,000 | SH | SOLE | 100,000 | 0 | 0 | ||
ESSA PHARMA INC | COM NEW | 29668H708 | 5,928 | 207,500 | SH | SOLE | 207,500 | 0 | 0 | ||
FATE THERAPEUTICS INC | COM | 31189P102 | 16,056 | 185,000 | SH | SOLE | 185,000 | 0 | 0 | ||
GALAPAGOS NV | SPON ADR | 36315X101 | 5,167 | 75,000 | SH | SOLE | 75,000 | 0 | 0 | ||
HARMONY BIOSCIENCES HLDGS IN | COM | 413197104 | 3,529 | 125,000 | SH | SOLE | 125,000 | 0 | 0 | ||
HELIX ACQUISITION CORP | COM CL A | G4444C102 | 5,175 | 500,000 | SH | SOLE | 500,000 | 0 | 0 | ||
IMMUNIC INC | COM | 4525EP101 | 3,249 | 265,000 | SH | SOLE | 265,000 | 0 | 0 | ||
IMMUNOVANT INC | COM | 45258J102 | 2,114 | 200,000 | SH | Call | SOLE | 200,000 | 0 | 0 | |
IOVANCE BIOTHERAPEUTICS INC | COM | 462260100 | 11,709 | 450,000 | SH | SOLE | 450,000 | 0 | 0 | ||
IVERIC BIO INC | COM | 46583P102 | 4,575 | 725,000 | SH | SOLE | 725,000 | 0 | 0 | ||
KADMON HLDGS INC | COM | 48283N106 | 3,096 | 800,000 | SH | SOLE | 800,000 | 0 | 0 | ||
KURA ONCOLOGY INC | COM | 50127T109 | 14,595 | 700,000 | SH | SOLE | 700,000 | 0 | 0 | ||
LARIMAR THERAPEUTICS INC | COM | 517125100 | 982 | 100,000 | SH | SOLE | 100,000 | 0 | 0 | ||
MERSANA THERAPEUTICS INC | COM | 59045L106 | 6,111 | 450,000 | SH | SOLE | 450,000 | 0 | 0 | ||
MERUS N V | COM | N5749R100 | 1,580 | 75,000 | SH | SOLE | 75,000 | 0 | 0 | ||
MIRATI THERAPEUTICS INC | COM | 60468T105 | 8,077 | 50,000 | SH | SOLE | 50,000 | 0 | 0 | ||
MODERNA INC | COM | 60770K107 | 940 | 4,000 | SH | SOLE | 4,000 | 0 | 0 | ||
OTONOMY INC | COM | 68906L105 | 1,004 | 450,000 | SH | SOLE | 450,000 | 0 | 0 | ||
PROVENTION BIO INC | COM | 74374N102 | 1,265 | 150,000 | SH | Put | SOLE | 150,000 | 0 | 0 | |
PROVENTION BIO INC | COM | 74374N102 | 843 | 100,000 | SH | SOLE | 100,000 | 0 | 0 | ||
RAPT THERAPEUTICS INC | COM | 75382E109 | 18,120 | 570,000 | SH | SOLE | 570,000 | 0 | 0 | ||
ROCKET PHARMACEUTICALS INC | COM | 77313F106 | 5,536 | 125,000 | SH | SOLE | 125,000 | 0 | 0 | ||
SATSUMA PHARMACEUTICALS INC | COM | 80405P107 | 6,375 | 904,225 | SH | SOLE | 904,225 | 0 | 0 | ||
SIERRA ONCOLOGY INC | COM NEW | 82640U404 | 3,894 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | ||
SPDR SER TR | S&P BIOTECH | 78464A870 | 40,620 | 300,000 | SH | Call | SOLE | 300,000 | 0 | 0 | |
SYNDAX PHARMACEUTICALS INC | COM | 87164F105 | 15,024 | 875,000 | SH | SOLE | 875,000 | 0 | 0 | ||
TARSUS PHARMACEUTICALS INC | COM | 87650L103 | 4,927 | 170,000 | SH | SOLE | 170,000 | 0 | 0 | ||
TG THERAPEUTICS INC | COM | 88322Q108 | 6,982 | 180,000 | SH | SOLE | 180,000 | 0 | 0 | ||
TRILLIUM THERAPEUTICS INC | COM NEW | 89620X506 | 12,125 | 1,250,000 | SH | SOLE | 1,250,000 | 0 | 0 | ||
VAXCYTE INC | COM | 92243G108 | 3,264 | 145,000 | SH | SOLE | 145,000 | 0 | 0 | ||
VERONA PHARMA PLC | SPONSORED ADS | 925050106 | 6,540 | 1,000,000 | SH | SOLE | 1,000,000 | 0 | 0 | ||
VIRIDIAN THERAPEUTICS INC | COM | 92790C104 | 6,402 | 350,000 | SH | SOLE | 350,000 | 0 | 0 | ||
VISTAGEN THERAPEUTICS INC | COM NEW | 92840H202 | 6,300 | 2,000,000 | SH | SOLE | 2,000,000 | 0 | 0 | ||
XENON PHARMACEUTICALS INC | COM | 98420N105 | 15,827 | 850,000 | SH | SOLE | 850,000 | 0 | 0 |